ConductScience.org, home

Paper474195

Resolution of renal amyloidosis secondary to rheumatoid arthritis.

Falck HM and 3 others. Acta Med Scand, 1979. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Papers, record 474195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/474195

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resolution of renal amyloidosis secondary to rheumatoid arthritis.
PubMed
Journal
Acta Med Scand
PubMed
Year
1979
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2019-08-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Falck HMH M
2Törnroth TT
3Skrifvars BB
4Wegelius OO

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmyloidosisMajor topic
Arthritis, RheumatoidMajor topic
Nephrotic SyndromeMajor topic
Basement Membrane
Capillaries
Cyclophosphamide
Female
Follow-Up Studies
Humans
Kidney Glomerulus
Middle Aged
Prednisone

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
25,197,587Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.Case Rep Nephrol2014https://conductscience.org/library/papers/25197587PubMed
14,677,008Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.Clin Rheumatol2003https://conductscience.org/library/papers/14677008PubMed
8,616,421Grand rounds--Hammersmith Hospital. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome.BMJ1996https://conductscience.org/library/papers/8616421PubMed
8,305,072Xanthogranulomatous pyelonephritis and amyloidosis.Pediatr Nephrol1993https://conductscience.org/library/papers/8305072PubMed
8,124,919Colchicine induced remission in amyloid nephrotic syndrome.Clin Rheumatol1993https://conductscience.org/library/papers/8124919PubMed
3,500,678Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.Ann Rheum Dis1987https://conductscience.org/library/papers/3500678PubMed
2,242,306Renal amyloidosis in juvenile chronic arthritis: evolution after chlorambucil treatment.Pediatr Nephrol1990https://conductscience.org/library/papers/2242306PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/474195

GET https://conductscience.org/api/papers/v1/474195/authors